Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 1657-1662

  Shen, Fei ^a   Xue, Xinjian ^a   Weber, George ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genistein; Human breast carcinoma cells; Inositol 1,4,5 trisphosphate; Signal transduction; Synergistic down regulation; Tamoxifen

Indexed keywords

ANTIESTROGEN; GENISTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; TAMOXIFEN; TRANSFERASE INHIBITOR;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CLONOGENIC ASSAY; COLONY FORMATION; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA; CELL CYCLE; CELL DIVISION; DRUG SYNERGISM; ENZYME INHIBITORS; ESTROGEN ANTAGONISTS; FEMALE; GENISTEIN; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0032781422     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Weber G, Shen F, Yang H, Prajda N and Li W: Amplification of signal transduction capacity and down-regulation by drugs. Advan Enzyme Regul 39: Accepted, June, 1999.
2. Weber G, Shen F, Yang H, Li W and Prajda N: Regulation of signal transduction in normal and cancer cells. Anticancer Res: Accepted, 1999.
3. Shen F and Weber G: Tamoxifen down-regulates signal transduction and is synergistic with tiazofurin in human breast carcinoma MDA-MB-435 cells. Oncol Res 10: 325-331, 1998.
4. Charlier C, Chariot A, Antoine N, Merville M, Gielen J and Castronovo V: Tamoxifen and its active metabolites inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem Pharmacol 49: 351-358; 1995.
5. Perry RR, Kang Y and Greaves B: Effect of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann Surgical Oncol 2: 238-245, 1995.
6. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet RA, Doody LA, Malone WF, Hawk ET and Sigman CC: New agents for chemoprevention. J Cellular Biochem 26: 1-28, 1996.
7. Zhou JR, Mukherjee P, Gugger ET, Tanaka T, Blackburn GL and Clinton SK: Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 58: 5231-5238, 1998.
8. Friedman ZY: The antitumor agent tamoxifen inhibits breakdown of polyphosphoinositides in GH4C. cells. J Pharmacol Exp Ther 271: 238-245, 1994.
9. Cheng AL, Chuang SE, Fine RL, Yeh KH, Liao CM, Lay JD and Chen DS: Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochem Pharmacol 55: 523-531, 1998.
10. ++ mobilization in human platelets by affecting polyphosphoinositidc turnover. Biochem Pharmacol 46: 395-403. 1993.
11. 1 phase. Cancer Res 43: 3583-3585, 1983.
12. Ercoli M, Scambia G, Fattotossi A, Raspaglio G, Battaglia A, Cicchillitti L, Malorni W, Rainaldi G, Panici PB and Mancuso S: Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line. Int J Cancer 76: 47-54, 1998.
13. Shao ZM, Alpaugh ML, Fontana JA and Barsky SH: Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21 WAFl/ClPl induclion, G2/M arrest, and apoptosis. J Cellular Biochem 69: 44-54, 1998.
14. Peterson G and Barnes S: Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179: 661-667, 1991.
15. Macinga D, Jain V, Sizemore N, Gorodeski GI, Eckert RL and Rorke EA: Tamoxifen regulation of ectocervical cell differentiation. J Soc Gynecol Investig 2(6): 754-761, 1995.
16. Constantinou A and Huberman E: Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action (43841). Proc Soc Exptl Biol Med 208: 109-115, 1995.
17. Shen F and Weber G: Synergistic action of quercetin and genistein in human ovarian carcinoma cells. Oncol Res 9: 597-602, 1997.
18. Singhal RL, Prajda N, Yeh Y and Weber G: 1-phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme. Cancer Res 54: 5574-5578, 1994.
19. Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Advan Enzyme Regul 22: 27-55, 1984.
20. Webb JL: Enzyme and metabolic inhibitors, vol. 1. New York: Academic Press: 107-510, 1963.
21. Berenbaum MC: Criteria for analyzing interaction between biological active agents. Advan Cancer Res 55: 269-335, 1981.
22. Guthrie N, Gapor A, Chambers AF and Carroll KK: Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J Nutr 127: 554s-548s, 1997.
23. So FV, Guthrie N, Chambers AF, Moussa M and Carroll K: Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 26: 167-181, 1996.
24. Johnston SRD, Haynes BP, Sacks NPM, McKinna JA, Griggs LJ, Jarman M, Baum M, Smith IE and Dowsett M: Effect of estrogen receptor status and time on the intra- tumoral accumulation of tamoxifen and N-dismethyltamoxifen following short-term therapy in human primary breast cancer. Breast Cancer Res Treat 28: 241-250, 1993.
25. Zava DT and Duwe G: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27(1): 31-40, 1997.
26. Weber G, Shen F, Prajda N, Li W, Csokay B, Olah E and Look KY: Regulation of signal transduction program by drugs. Advan Enzyme Regul 37: 35-55, 1997.
27. Singhal RL, Yeh Y, Look KY, Sledge GW Jr and Weber G: Coordinated increase in activities of the signal transduction enzymes Pl kinase and PIP kinase in human cancer cells. Life Sci 55: 1487-1492, 1994.
28. Junghahn I, Bergmann J, Langen P, Thun I, Vollgraf C and Brachwitz H: Effect of ALP analogs on inositol trisphosphate formation in H184 mammary epithelial cells before and after transfection with v-erb B oncogene. Anticancer Res 15: 449-454, 1995.
29. Peterson G: Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125: 784s-789s, 1995.